ARTICLE | Finance
Synthego scales up
How CRISPR tools company Synthego plans to deploy its $110M series C
October 26, 2018 10:09 PM UTC
In light of growing demand for its CRISPR-based products, Synthego Corp. raised a $110 million series C round to ramp up commercialization of existing products and broaden its portfolio.
Founders Fund led the round, which closed on Oct. 23. Fellow existing investors 8VC and Menlo Ventures also participated...